Incyte Corporation | TalkMarkets

Latest Posts

How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities

Article By: Hashtag Investing

Saturday, June 17, 2023 2:00 PM EDT

The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators that are spearheading advancements in biotech.

In this article: ALNY, INCY, JAZZ, REGN, SGEN, VRTX, MRNA, IONS, NTLA, CRSP

Read

Which S&P 500 Stocks Look Most Attractive Now?

Article By: Herbert Blank

Wednesday, March 8, 2023 5:34 PM EDT

Using ValuEngine’s advanced screening tool, we select 4- and 5-rated stocks in the SPY ETF. As we can see in the table below, 20 stocks passed the screen with two strong buys; CEG and NCLH.

In this article: SCHD, ALL, CCL, DAL, LNC, LUV, UAL, INCY, NFLX, AAL, NCLH, ETSY, CEG, COWZ, NVDA

Read

BriaCell Therapeutics' Mission: Destroy Breast Cancer

Article By: Lorimer Wilson

Wednesday, January 18, 2023 9:59 AM EDT

BriaCell would make a great buy and hold investment. If, and when, it brings a product directly to market, or is acquired by a major pharmaceutical company, its stock price should go up dramatically.

In this article: WWWW, BCTX, BCTXW Also: INCY

Read

Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion

Article By: ChinaBio® Today

Saturday, December 31, 2022 2:30 PM EDT

China Biopharma deal activity in 2022 was certainly slower than the previous year, but the ten largest deals, many of them booked in the second half of the year, totaled a decent $21.5 billion by themselves.

In this article: MRK, HKMPF, INCY, WXXWY

Read